Alakesh Bera

895 total citations
31 papers, 324 citations indexed

About

Alakesh Bera is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alakesh Bera has authored 31 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Alakesh Bera's work include Prion Diseases and Protein Misfolding (6 papers), S100 Proteins and Annexins (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Alakesh Bera is often cited by papers focused on Prion Diseases and Protein Misfolding (6 papers), S100 Proteins and Annexins (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Alakesh Bera collaborates with scholars based in United States, France and India. Alakesh Bera's co-authors include Pradip Nandi, James W. Freeman, Harvey B. Pollard, P Sizaret, Kolaparthi Venkatasubbarao, Meera Srivastava, Sajal Biring, Ofer Eidelman, Lin Cao and Shujie Zhao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Alakesh Bera

27 papers receiving 324 citations

Peers

Countries citing papers authored by Alakesh Bera

Since Specialization

Citations

This map shows the geographic impact of Alakesh Bera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alakesh Bera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alakesh Bera more than expected).

Fields of papers citing papers by Alakesh Bera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alakesh Bera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alakesh Bera. The network helps show where Alakesh Bera may publish in the future.

Co-authorship network of co-authors of Alakesh Bera

This figure shows the co-authorship network connecting the top 25 collaborators of Alakesh Bera. A scholar is included among the top collaborators of Alakesh Bera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alakesh Bera. Alakesh Bera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PDE4 inhibitor rolipram represses hedgehog signaling via ubiquitin-mediated proteolysis of GLI transcription factors to regress breast cancer 2025 ·Journal of Biological Chemistry ·(unknown), (unknown), Alakesh Bera, (unknown), Urmi Chatterji, Arunima Biswas	1
2	Experimental and theoretical studies on piperidine-based heteroleptic Schiff base Ni(ii) and Cu(ii) complexes investigating DNA/protein binding and anticancer activities 2025 ·New Journal of Chemistry ·(unknown), Manik Das, Somali Mukherjee, (unknown), Alakesh Bera, Arunima Biswas, (unknown), Paula Brandão, (unknown), Bidhan Chandra Samanta, Tithi Maity	0
3	Blood-Based Lateral-Flow Immunoassays Dipstick Test for Damaged Mitochondrial Electron Transport Chain in Pyruvate Treated Rats with Combined Blast Exposure and Hemorrhagic Shock 2025 ·Journal of Clinical Medicine ·(unknown), Biswajit Saha, (unknown), Alakesh Bera, Pushpa Sharma	2
4	Role of Annexin 7 (ANXA7) as a Tumor Suppressor and a Regulator of Drug Resistance in Thyroid Cancer 2024 ·International Journal of Molecular Sciences ·Alakesh Bera, (unknown), Narayanan Puthillathu, Madhan Subramanian, (unknown), Eric Russ, Harvey B. Pollard, Meera Srivastava	1
5	Cell surface marker-based capture of neoantigen-reactive CD8⁺ T-cell receptors from metastatic tumor digests 2023 ·Journal for ImmunoTherapy of Cancer ·Praveen D. Chatani, Frank J. Lowery, Neilesh B. Parikh, Kyle Hitscherich, Rami Yossef, Victoria Hill, Jared J. Gartner, Biman C. Paria, Maria Florentin, Satyajit Ray, Alakesh Bera, (unknown), Paul F. Robbins, Sri Krishna, Steven A. Rosenberg	13
6	Circulating Cell-free DNA in Serum as a Marker for the Early Detection of Tumor Recurrence in Breast Cancer Patients 2022 ·Cancer Diagnosis & Prognosis ·Alakesh Bera, Eric Russ, (unknown), (unknown), (unknown), Madhan Subramanian, Matthew T. Hueman, Harvey B. Pollard, Hai Hu, Craig D. Shriver, Meera Srivastava	5
7	Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells 2021 ·Scientific Reports ·H. Caohuy, Ofer Eidelman, (unknown), Shufeng Liu, Qingfeng Yang, Alakesh Bera, (unknown), Tony T. Wang, Harvey B. Pollard	18
8	Abstract 4322: EXOSC4, a novel gene at chromosome 8q24 loci is linked with breast cancer progression and is a prognostic marker for breast cancer survival 2020 ·Cancer Research ·Alakesh Bera, (unknown), Madhan Subramanian, (unknown), Eric Russ, Harvey B. Pollard, Hai Hu, Craig D. Shriver, Meera Srivastava	0
9	Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression 2018 ·PLoS ONE ·Ximena Leighton, Alakesh Bera, Ofer Eidelman, Lukas Bubendorf, Tobias Zellweger, Jaideep Banerjee, Edward P. Gelmann, Harvey B. Pollard, Meera Srivastava	6
10	Cyclin E and FGF8 are downstream cell growth regulators in distinct tumor suppressor effects of ANXA7 in hormone-resistant cancer cells of breast versus prostate origin. 2018 ·PubMed ·Alakesh Bera, (unknown), Harvey B. Pollard, Meera Srivastava	7
11	A quantitative characterization of interaction between prion protein with nucleic acids 2018 ·Biochemistry and Biophysics Reports ·Alakesh Bera, Sajal Biring	11
12	High ANXA7 Potentiates Eucalyptol Toxicity in Hormone-refractory Prostate Cancer 2018 ·Anticancer Research ·Ximena Leighton, Alakesh Bera, Ofer Eidelman, (unknown), Narayanan Puthillathu, Harvey B. Pollard, Meera Srivastava	12
13	Vitamin D in Prostate Cancer 2015 ·Vitamins and hormones ·Jungmi Ahn, Sul-Gi Park, (unknown), Alakesh Bera, Chung S. Song, Bandana Chatterjee	20
14	A miRNA Signature of Chemoresistant Mesenchymal Phenotype Identifies Novel Molecular Targets Associated with Advanced Pancreatic Cancer 2014 ·PLoS ONE ·Alakesh Bera, Kolaparthi Venkatasubbarao, (unknown), (unknown), James W. Freeman	49
15	DNA Binding and Condensation Properties of the Herpes Simplex Virus Type 1 Triplex Protein VP19C 2014 ·PLoS ONE ·Alakesh Bera, Edward M. Perkins, Jian Zhu, Heng Zhu, Prashant Desai	8
16	Oncogenic K-Ras and Loss of Smad4 Mediate Invasion by Activating an EGFR/NF-κB Axis That Induces Expression of MMP9 and uPA in Human Pancreas Progenitor Cells 2013 ·PLoS ONE ·Alakesh Bera, Shujie Zhao, Lin Cao, Paul J. Chiao, James W. Freeman	31
17	Expression of the HSV-1 capsid protein VP19C in Escherichia coli: A single amino acid change overcomes an expression block of the full-length polypeptide 2010 ·Protein Expression and Purification ·(unknown), (unknown), Alakesh Bera, (unknown), (unknown), Prashant Desai	3
18	Bending and Unwinding of Nucleic Acid by Prion Protein 2007 ·Biochemistry ·Alakesh Bera, (unknown), Pradip Nandi	27
19	Biological polyamines inhibit nucleic-acid-induced polymerisation of prion protein 2007 ·Archives of Virology ·Alakesh Bera, Pradip Nandi	11
20	Osmolyte Trimethylamine N-Oxide Converts Recombinant α-Helical Prion Protein to its Soluble β-Structured Form at High Temperature 2006 ·Journal of Molecular Biology ·Pradip Nandi, Alakesh Bera, P Sizaret	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact